Emmanuelle Menoret
Nantes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma.
Journal: Haematologica
Published: September 21, 2023
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.
Journal: Nature communications
Published: July 31, 2023
Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways.
Journal: Journal of hematology & oncology
Published: July 12, 2018
A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 23, 2015
Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma.
Journal: Oncotarget
Published: March 27, 2015
A simple flow cytometry-based barcode for routine authentication of multiple myeloma and mantle cell lymphoma cell lines.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: December 02, 2014
Cell death via DR5, but not DR4, is regulated by p53 in myeloma cells.
Journal: Cancer research
Published: June 29, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026